Foresight Environmental Infrastructure Limited (FGEN) reported resilient FY2026 financial results, highlighting the strength of its diversified environmental infrastructure portfolio and self-sustaining growth strategy. The company delivered a 6.2% NAV total return, supported by stable cash generation, active portfolio management, and value-accretive investments across clean transport and anaerobic digestion assets. Net asset value stood at £656 million, with NAV per share of 105.2p, while dividend cover remained robust at 1.25x. FGEN increased its FY2027 target dividend by 1% to 8.04p per share, marking a twelfth consecutive year of dividend growth. The £759 million portfolio benefits from broad exposure to renewable energy generation, energy transition infrastructure, waste management, and sustainable resource assets, reducing reliance on power prices and enhancing revenue resilience through diversified income streams, inflation linkage, and contracted revenues. Growth platforms such as CNG Fuels, controlled environment agriculture, and biomethane infrastructure continued to progress, with CNG Fuels more than doubling EBITDA to £14.2 million and providing guidance for further growth in FY2027. The company maintained a conservative balance sheet, with overall gearing below 30%, and completed follow-on investments generating mid-teen returns. Management remains focused on delivering a progressive dividend, organic NAV growth, disciplined capital allocation, and long-term shareholder value through a scalable model that does not rely on new equity issuance. FGEN continues to target annual NAV total returns of 8–10%, underpinned by resilient operational performance, embedded growth opportunities, and proactive asset management.

CELLBXHEALTH PLC provided an investor update highlighting its strategic transformation into a commercially focused precision oncology company, leveraging its proprietary circulating tumour cell (CTC) technology platform to improve cancer diagnostics, patient monitoring, and drug development. The company reported significant operational restructuring, delivering more than £6.6 million in annualised cost savings, reducing headcount by over 60%, and establishing a clear pathway towards positive EBITDA by late 2028. Management expects revenue growth of approximately 50% in 2026, supported by a growing commercial pipeline and strategic partnerships with AstraZeneca, AdventHealth, and NHS-led clinical programmes. Operating in a rapidly expanding liquid biopsy market forecast to exceed $1.1 billion by 2031, CELLBXHEALTH is positioned to capitalise on increasing demand for advanced cancer testing solutions that complement traditional tissue biopsy and circulating tumour DNA analysis. The company’s platform is supported by over 250,000 processed samples, 120+ peer-reviewed publications, 102 installed instruments across 61 sites, and a robust intellectual property portfolio. Management highlighted multiple near-term growth catalysts, including biopharma collaborations, NHS lung cancer programme data, expanded laboratory services, and further commercial agreements. With £4.3 million of cash at the end of Q1 2026, improved gross margin targets, a streamlined cost base, and a focus on revenue-generating opportunities, CELLBXHEALTH remains focused on accelerating commercial adoption, expanding its market presence, and delivering long-term shareholder value.

RWS Holdings PLC delivered a strong first-half performance for FY2026, reporting 7% organic constant currency revenue growth and a 28% increase in adjusted operating profit, demonstrating the effectiveness of its refreshed operating model, AI-led innovation strategy, and efficiency programme. Revenue reached £360 million, supported by robust demand in its Train AI business, while adjusted operating margins improved by 130 basis points and cash generation exceeded guidance. The company continues to strengthen its position as a leading provider of AI-enabled language, content, and intellectual property solutions, serving 85 of the world’s top 100 brands. Key strategic developments included the launch of Language Weaver Pro, recognised as a leading enterprise translation engine, the acquisition of trademark protection specialist Obviously, and the expansion of AI-related products and services to nearly one-third of group revenue. RWS also reported strong customer retention, with spending from its top 100 clients increasing 9% year-on-year, alongside improving recurring SaaS revenues and continued investment in product innovation, cloud infrastructure, and operational efficiencies. Despite foreign exchange headwinds, the company maintained its outlook for mid-single-digit organic revenue growth and further margin expansion, underpinned by a scalable business model, low leverage, and a progressive dividend policy. Management remains focused on accelerating growth through AI adoption, enhanced go-to-market execution, and long-term value creation for shareholders.

Pan African Resources PLC provided a positive investor update highlighting strong operational and financial performance, driven by a 40% increase in gold production and continued growth across its diversified portfolio of gold assets in South Africa and Australia. The company expects to deliver approximately 275,000 ounces of annual production while remaining within all-in sustaining cost (AISC) guidance despite inflationary pressures on energy, labour, reagents, and diesel. Strong performances from Elikhulu, MTR, Evander Mines, and Barberton Mines offset lower-than-expected production from the Tennant operation in Australia. Supported by record gold prices, Pan African reported a robust balance sheet with more than $200 million in cash, positioning the group to fund growth projects while maintaining its progressive dividend strategy. Key growth initiatives include the Soweto tailings retreatment project, the high-grade White Devil deposit in Australia, and the Poplar project at Evander, all of which offer significant production and resource expansion potential. Management remains focused on increasing production, improving operational efficiencies, expanding renewable energy capacity, and controlling costs through long-life, low-cost assets. The company also highlighted its sector-leading ESG initiatives, including major solar and water treatment investments, while emphasizing strong shareholder returns, attractive margins, long-dated mining rights, and a substantial resource base following the Emerson acquisition and planned ASX listing.

The Global Smaller Companies Trust PLC provided an investor update highlighting improving conditions for global small-cap equities, which management believes may be entering a new growth cycle after years of underperformance against large-cap stocks. The trust reported a 20.9% increase in NAV over the last 12 months and a 28.8% share price return, supported by discount narrowing and enhanced shareholder engagement. While performance lagged the benchmark due to a disciplined focus on quality businesses and limited exposure to speculative AI-driven stocks, management remains committed to its long-term investment philosophy centred on high-quality, cash-generative companies trading at attractive valuations. Recent strategic initiatives include benchmark changes, portfolio concentration from 213 to 125 holdings, reduced UK exposure, improved discount management, and refinements to stock selection and risk controls. The portfolio currently exhibits superior profitability, stronger margins, lower leverage, and more attractive valuation metrics than its benchmark, trading at 11.9x EBITDA and 16.8x earnings. Management sees compelling opportunities in sectors such as industrials, consumer businesses and real estate services, while maintaining an underweight position in North America. The trust believes small caps offer investors diversification benefits, inflation resilience and exposure to undervalued growth opportunities, positioning shareholders to benefit from a potential rotation away from highly concentrated US technology stocks and a renewed preference for quality and value investing.

Forgent PLC provided an investor update outlining a major strategic milestone as it transitions into a focused Australian mining exploration company. The company confirmed that drilling at its flagship Peak Hill gold and copper project in Western Australia will commence imminently, with approximately 2,800 metres across 42 drill holes targeting historic high-grade mineralisation and results expected in August. Management highlighted significant exposure to two attractive commodity themes—gold and copper—supported by strong long-term demand fundamentals. Alongside Peak Hill, Forgent’s portfolio includes the Mount Shoal project, which contains a JORC-compliant mineral resource of 23.4 million tonnes and an exploration target of 80–150 million tonnes, offering substantial resource growth potential. The Green Rocks project also delivered encouraging exploration results, including copper grades of up to 29%, with drilling approvals being prepared. The company emphasised that its restructuring programme is largely complete, having strengthened the balance sheet, reduced costs, simplified operations, and repositioned the business for exploration-led value creation. Management stated that the company is fully funded for its current drilling programme and remains focused on execution, near-term catalysts, and shareholder value. With multiple exploration assets, exposure to gold, copper and nickel, and a series of upcoming drilling and assay results, Forgent believes it is well positioned to deliver growth and unlock value through resource expansion and exploration success.